Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our strategy employs molecular simulations to explore an extensive range of proteins, capturing their dynamics both individually and within complexes with other proteins. Through ensemble virtual screening, we address proteins' conformational mobility, uncovering key binding sites at both functional regions and remote allosteric locations. This comprehensive investigation ensures a thorough assessment of all potential mechanisms of action, with the goal of discovering innovative therapeutic targets and lead molecules across across diverse biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q13496
UPID:
MTM1_HUMAN
Alternative names:
Phosphatidylinositol-3,5-bisphosphate 3-phosphatase; Phosphatidylinositol-3-phosphate phosphatase
Alternative UPACC:
Q13496; A6NDB1; B7Z491; F2Z330; Q8NEL1
Background:
Myotubularin, known for its roles as Phosphatidylinositol-3,5-bisphosphate 3-phosphatase and Phosphatidylinositol-3-phosphate phosphatase, is pivotal in lipid phosphatase activity, impacting cellular processes such as EGFR degradation, vacuolar formation, and mitochondrial positioning. Its involvement in skeletal muscle maintenance and the regulation of desmin intermediate filaments underscores its biological significance.
Therapeutic significance:
Linked to Myopathy, centronuclear, X-linked, a disorder characterized by progressive muscular weakness, Myotubularin's genetic variants offer a target for therapeutic intervention. Understanding its role could pave the way for novel treatments, emphasizing the protein's potential in combating muscle-related diseases.